BTIG Remains Positive on NeoGenomics (NEO) Following Q4 Results, Guidance; Affirms at 'Buy'

Go back to BTIG Remains Positive on NeoGenomics (NEO) Following Q4 Results, Guidance; Affirms at 'Buy'
NEOGENOMICS (NASDAQ: NEO) Delayed: 17.04 +0.42 (2.53%)
Previous Close $16.62    52 Week High $9.54 
Open $16.62    52 Week Low $5.49 
Day High $17.30    P/E 426.00 
Day Low $16.54    EPS $0.04 
Volume 1,493,569